Cost-Effectiveness Analysis of Ocrelizumab for the Treatment of Relapsing and Primary Progressive Multiple Sclerosis in Portugal

AuthID
 P-00X-TK7
8
Author(s)
Martins, P
·
Vandewalle, B
·
Felix, J
·
Capela, CM
·
Salgado, AV
·
Ferreira, DG
·
Monteiro, I
Tipo de Documento
Article in Press
Year published
2022
Publicado
in PHARMACOECONOMICS-OPEN, ISSN: 2509-4262
Volume: 7, Número: 2, Páginas: 229-241 (13)
Indexing
Wos®
Scopus®
Crossref®5
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 36454397
SCOPUS: 2-s2.0-85143291079
Wos: WOS:000912631500001
Source Identifiers
ISSN: 2509-4262
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service